Angelini Pharma
  • Angelini Pharma Worldwide
    • Austria
    • Bulgaria
    • Czech Republic
    • France
    • Germany
    • Greece
    • Hungary
    • Italy
    • Nordics
    • Poland
    • Portugal
    • Romania
    • Russia
    • Slovakia
    • Spain
    • Switzerland
    • Turkey
    • United Kingdom
    • United States
  • Angelini Pharma
  • Who we are

    • About us
    • Vision, purpose & values
    • Production Plants
    • Key Financials
    • People
    • What we do
    • Key facts and events
  • Core areas

    • Brain Health
    • Consumer Health
  • R&D

    • Science & Innovation
    • Clinical Trials
    • Research collaborations
    • Independent Research (IIT/RIS)
  • Partnering
  • Our Responsibility

    • Sustainability
    • Projects
    • Diversity & Inclusion
    • Ethics
    • Quality and EHS
    • Transparency
  • Media

    • News
    • Press releases
    • Press kit
    • Media center
  • Career Opportunities
  • Open main menu
  • Open main menu
  • Search

    Search

  1. Angelini Pharma
  2. Our responsibility
  3. Transparency
  4. Netherlands

Netherlands

Angelini Pharma France SAS has fulfilled reporting obligations per local requirements. Disclosures are available on the Foundation for the Code for Pharmaceutical Advertising (CGR) website: Stichting Transparantieregister Zorg - Home. Inquiries may be submitted to quality_netherlands@angelinipharma.com.

 

2021

Netherlands - Transparency Report

Share

  • Twitter
  • Facebook
  • Linkedin
  • Top Employer Europe 2025
  • Privacy
  • Cookie Policy
  • Terms of use
  • Accessibility declaration
  • Webscraping
  • Transparency
  • Contact
  • Site map
  • Credits
  • Cookie settings
  • Twitter
  • Linkedin
  • Instagram

Angelini Pharma S.p.a. - Viale Amelia 70, 00181 Roma - P.IVA 01258691003 e C.F. Numero di iscrizione registro imprese: 03907010585 - Ufficio del registro delle imprese: Roma - Capitale: € 165.000.000 I.V.
Copyright 2025 © Angelini S.p.a. - All Rights Reserved

Part of Angelini Industries

Close menu